1 

 

2018 AACR Annual Meeting Minisymposia Chairpersons

Clinical Trials Minisymposia Sunday, April 15, 2018, 3:00 pm - 5:00 pm New Treatment Approaches for Breast and Ovarian Cancer Leisha A. Emens Johns Hopkins University School of Medicine Baltimore, MD emensle@jhmi.edu

Monday, April 16, 2018, 3:00 pm - 5:00 pm Updates in Immuno-oncology Trials Michael B. Atkins Georgetown Lombardi Comprehensive Cancer Center Washington, DC mba41@georgetown.edu

Tuesday, April 17, 2018, 2:45 pm - 5:00 pm Biomarkers in Immuno-oncology Kurt Alex Schalper Yale University New Haven, CT kurt.schalper@yale.edu

2 

 

Regular Abstract Minisymposia Sunday, April 15, 3:00pm- 5:00pm Patient-Derived Models of Cancer: Present and Future Dr. Elisa De Stanchina Memorial Sloan Kettering Cancer Center 417 E 68th Street New York, NY 10065 (646) 888-2142 destance@mskcc.org Dr. Katerina A. Politi Associate Professor, Dept. of Pathology Yale Cancer Ctr. Yale Univ. School of Medicine 310 Cedar St, SHM I-234D New Haven, CT 06520 (203) 737-5921 (203) 785-7531 katerina.politi@yale.edu

Novel Therapeutic Agents and Combinations Dr. Saul H. Rosenberg Sr. Director, Oncology Discovery AbbVie Inc. 1 N. Waukegan Rd. AP10-LL, Dept. R460 North Chicago, IL 60064-6098 (847) 937-6189 (847) 935-5165 saul.h.rosenberg@abbvie.com Dr. Vincent L. Giranda, V Distinguished Scientist Merck Research Laboratories 351 N. Sumneytown Pike UG4D72 North Wales, PA 19454 (267) 305-0279 vincent.giranda@merck.com

3 

 

Novel Roles of Steroid Hormone Receptors Dr. Suzanne A.W. Fuqua Professor of Medicine, Breast Ctr. Baylor College of Medicine, Dan L. Duncan Cancer Ctr. Ms: BCM600, 1220 Alkek One Baylor Plaza Houston, TX 77030 (713) 798-1671 (713) 798-1659 sfuqua@bcm.edu Dr. Jennifer K. Richer Professor, Dept. of Pathology Univ. of Colorado Anschutz Medical Campus 12800 E. 19th Ave. P18/5122 Ms: 8104 Aurora, CO 80045 (303) 724-3735 (303) 724-3712 jennifer.richer@ucdenver.edu

Epigenetic Mechanisms of Tumor Progression Dr. Carol A. Lange Professor, Dept. of Medicine and Pharmacology Univ. of Minnesota Masonic Cancer Ctr. 2231 6th Street SE Room 3-126 Minneapolis, MN 55455 (612) 626-0621 lange047@umn.edu Dr. Jonna M. Frasor Associate Professor, Dept. of Physiology & Biophysics Univ. of Illinois at Chicago Mc: 901, Room E202 835 S. Wolcott Chicago, IL 60612 (312) 355-2583 (312) 996-1414 jfrasor@uic.edu

4 

 

Cell Signaling Pathways Dr. Dianne Cox Albert Einstein College of Medicine Jack and Pearl Resnick Campus 1300 Morris Park Avenue Bronx, NY 10461 718.430.4005 dianne.cox@einstein.yu.edu Dr. Lucio Miele Professor and Director for Inter-Institutional Programs LSU Stanley S. Scott Cancer Ctr. 1700 Tulane Ave. New Orleans, LA 70112 (504) 210-3433 (504) 210-2970 lmiele@lsuhsc.edu

Radiation Science Prof. Bruce F. Kimler Professor, Dept. of Radiation Oncology Univ. of Kansas Medical Ctr. 3901 Rainbow Blvd. Kansas City, KS 66160-7321 (913) 588-4523 bkimler@kumc.edu

Computational Methods and Resources for Cancer Research Dr. Roel Verhaak Professor, Assoc Director of Computational Biology The Jackson Laboratory 10 Discovery Drive Suite 4305 Farmington, CT 06032 (860) 837-2105 roel.verhaak@jax.org

5 

 

Dr. Steven G. Rozen Professor Duke-NUS Graduate Medical School 8 College Road Duke-NUS Medical School SINGAPORE 169857 +65 9857-3213 steve.rozen@duke-nus.edu.sg

Liquid Biopsy Dr. Peter Kuhn Dean's Prof of Bio Sci, Prof of Med, Bio Engineer, and Aerospace & Mech Eng. USC 3430 S Vermont Avenue TRF 114A, MC3303 Los Angeles, CA 90089-3303 (213) 821-3980 (213) 821-7854 pkuhn@usc.edu Prof. Caroline Dive Deputy Director & CEP Group Leader Cancer Research UK Manchester Inst. Wilmslow Rd. Manchester M20 4BX ENGLAND +44 (161) 446-3036 +44 (161) 446-3019 caroline.dive@cruk.manchester.ac.uk

Molecules Addressing Challenges in Drug Discovery Dr. Vinod F. Patel Chief Scientific Officer TME Therapeutics LLC 3 Mossy Ln. Acton, MA 01720 (978) 264-4043 vinodfpatel@tmetherapeutics.com

6 

 

Dr. Jim Bischoff Global Head Targeted Therapy - Oncology Roche Grenzacherstrasse 124 Bau 70 / 305 4070 Basel SWITZERLAND +41796043037 james_robert.bischoff@roche.com

Building the Microenvironment through Crosstalk Dr. Sheila A. Stewart Professor, Div. of Cell Biology & Physiology Washington Univ. Campus Box 8228, Room 514 660 S. Euclid Ave. St. Louis, MO 63110-1093 (314) 362-7437 (314) 362-7463 Sheila.stewart@wustl.ed Dr. Sandra S. Mcallister Assitant Professor of Medicine Harvard Medical School HIM 743 77 Avenue Louis Pasteur Boston, MA 02115 (617) 525-4929 (617) 525-4986 smcallister1@bwh.harvard.edu

Engineering Immunotherapies for Anticancer Activity Dr. Daniel S. Chen Vice President, Global Head of Cancer Immunotherapy Genentech, Inc. 1 DNA Way Building 44, MS: 44-2B South San Francisco, CA 94080-4990 (650) 467-4421 (650) 467-3165 Chen.Daniel@gene.com

7 

 

Dr. Antoni Ribas Professor, Medicine, Surgery and Molec. & Med. Pharmacology UCLA Medical Ctr. 10833 Le Conte Ave. 11-934 Factor Bldg. Los Angeles, CA 90095 (310) 206-3928 (310) 825-2493 aribas@mednet.ucla.edu

Monday, April 16, 3:00pm- 5:00pm Molecular Predictors of Response, Mediators of Resistance, Mechanisms of Action, Pharmacodynamic Markers, and Novel Disease Subsets Dr. Catherine C. Smith Assistant Professor, Dept. of Med./Hem.-Onc. UCSF 505 Parnassus Ave. Box 1270 San Francisco, CA 94143 (415) 476-9553 (415) 476-3726 csmith@medicine.ucsf.edu Dr. Roger S. Lo Associate Professor, Dept. of Dermatology UCLA CHS 52-121 10833 Le Conte Ave. Los Angeles, CA 90095 (310) 825-0286 (310) 206-9878 rlo@mednet.ucla.edu

8 

 

Cancer Epigenetics and Epigenetic Therapy Dr. Daniel DeCarvalho Princess Margaret Cancer Centre Univ. Health Network Princess Margaret Hospital 610 University Ave. Toronto, ON M5T 2M9 CANADA (416) 946-4545 ddecarv@uhnres.utoronto.ca Dr. Cheryl Arrowsmith Senior Scientist Univ. Health Network Ontario Cancer Inst. 610 University Ave., 7-504 Toronto, ON M5G 2M9 CANADA 416-946-0237 416-946-0880 carrow@uhnresearch.ca

Survivorship and Disparities Dr. Anna D. Barker Co-Director, Complex Adaptive Systems Arizona State Univ. 6711 E. Camelback Road Unit 50 Scottsdale, AZ 85251 (480) 727-0898 (480) 965-8293 anna.barker@asu.edu Ms. Jeri Francoeur Board President The Susan G. Komen Breast Cancer Foundation Central Florida Affiliate 1 Sharon Terrace Ormond Beach, FL 32174 (386) 295-1554 jhfrancoeur@gmail.com  

9 

 

Organ-Specific Metastasis Dr. Ruth J. Muschel Dept. of Oncology Univ. of Oxford, Gray Inst. for Radiation Onc. Old Road Campus Research Bldg. Roosevelt Blvd. Oxford OX2 9AU ENGLAND +44 (1865) 225-847 +44 (1865) 857-127 ruth.muschel@oncology.ox.ac.uk Dr. Danny R. Welch Professor of Cancer Biology Univ. of Kansas Cancer Ctr. 3901 Rainbow Blvd. Mailstop 1071 Kansas City, KS 66106-2937 (913) 945-7739 dwelch@kumc.edu

Identification of Biomarkers and Molecular Drug Targets Prof. Harriet Wikman Researcher, Inst. of Tumor Biology Univ. Medical Ctr. Hamburg-Eppendorf Martinistrasse 52 Bldg. N27 Rm. 04.006 D-20246 Hamburg GERMANY +49 (40)741051913 +49 (40)741055379 h.wikman@uke.de Dr. Steven A. Johnsen Professor Univ. Medical Ctr. Goettingen Justus-von-Liebig-Weg 11 3.OG,AG Tumorepigenetik 37075 GOETTINGEN GERMANY +49 551 39 20830 steven.johnsen@med.uni-goettingen.de

10 

 

Deciphering Cancer Mechanisms in Animal Models Dr. Kathryn A. O'donnell Asst. Professor, Dept. of Molec. Bio. UT Southwestern Medical Center 6000 Harry Hines Blvd. NA6.300A Dallas, TX 75390-9148 (214) 648-5144 (214) 648-5190 kathryn.odonnell@utsouthwestern.edu Dr. Fotis Asimakopoulos Associate Professor, Medicine University of Wisconsin Madison 1111 Highland Avenue WIMR 4031 Madison, WI 53705 (608) 265-4835 fasimako@medicine.wisc.edu

Genetic and Molecular Epidemiology of Cancer Risk and Prognosis Dr. Michael E. Scheurer Associate Professor Baylor College of Medicine, Dan L. Duncan Cancer Ctr. One Baylor Plaza MS: BCM305 Houston, TX 77030 (713) 798-5547 scheurer@bcm.edu Dr. Michael B. Cook Investigator, DCEG National Cancer Institute 9609 Medical Center Drive 6E-430 Rockville, MD 20850 (240) 276-7298 (240) 276-7838 cookmich@mail.nih.gov

Use of Liquid Biopsies in Clinical Trials Dr. Costanza Paoletti

11 

 

Research Investigator, Dept. of Int. Med. Univ. of Michigan Comp. Cancer Ctr. 853 Greenhills Drive Ann Arbor, MI 48105 (734) 647-7250 (734) 647-9480 pcostanz@med.umich.edu

Sampling the Cancer Genome and the Epigenome: Opportunities and Exquisite Vulnerabilities Dr. Nada Jabado Professor, Dept. of Pediatrics McGill Univ. 1001 Decarie Blvd. Block E Res. Inst. Rm. EM1.2242 Montréal, QC H4A 3J1 CANADA 514-934-1934 ext 76163 nada.jabado@mcgill.ca Dr. Matthew L. Meyerson Professor of Pathology Dana-Farber Cancer Inst. 450 Brookline Ave. Boston, MA 02215 (617) 632-4768 (617) 582-7880 matthew_meyerson@dfci.harvard.edu

Drugging the Undruggable: Using Synthetic Lethality and Other Approaches to Develop New Treatment Strategies Dr. Tomoo Iwakuma Assoc. Professor, Dept. of Cancer Biology Univ. of Kansas Medical Ctr. 3901 Rainbow Blvd. Wahl East Rm. 2005 Kansas City, KS 66160 (913) 588-7412

12 

 

tiwakuma@kumc.edu Dr. Scott James Weir Assoc. Director, Translational Research Univ. of Kansas Medical Ctr. 2009 Wahl Hall West, MS 1027 3901 Rainbow Blvd. Kansas City, KS 66160 (913) 588-3729 sweir@kumc.edu

Tuesday, April 17, 3:00pm- 5:00pm Metabolism: Emerging Concepts and Therapy Dr. Sufi M. Thomas Assoc. Professor, Otolaryngology and Cancer Biology Univ. of Kansas Medical Ctr. 3020 Wahl Hall East 3901 Rainbow Blvd. Kansas City, KS 66160 (412) 805-2405 sthomas7@kumc.edu Dr. Mark W. Dewhirst Gustavo S. Montana Professor of Radiation Oncology Duke Univ. Medical Ctr. Box 3455 Med Ctr. 201 Med Sci Res Bldg. Research Drive Durham, NC 27710 (919) 684-1879 (919) 684-8718 mark.dewhirst@duke.edu

A Therapeutic "About Face": Reversing Drug Resistance Dr. Christine M. Lovly Asst. Professor of Medicine and Cancer Biology Vanderbilt Univ. School of Medicine 5724 Knob Road Nashville, TN 37209 (615) 936-3457 (615) 343-7602 christine.lovly@vanderbilt.edu

13 

 

Dr. Alexander E. Drilon Assistant Attending Physician, Dept. of Medicine Mem. Sloan Kettering Cancer Ctr. Solid Tumor Oncology 300 E 66th St. BAIC 1253 New York, NY 10065 (646) 888-4206 drilona@mskcc.org

Epigenetic and Metabolic Regulation of Cancer Immunity Dr. Juan R. Cubillos-Ruiz Assistant Professor of Microbiology & Immunology in Obstetrics and Gynecology, Weill Cornell Medicine 1300 York Ave., E-903 New York, NY 10065 (212) 746-1323 (212) 746-9215 jur2016@med.cornell.edu Dr. Steven Z. Josefowicz Weill Cornell Medical College 1300 York Avenue, Box 69 New York, NY 10065 212.746.2074 szj2001@med.cornell.edu

Stemness and Cancer Dr. Peter B. Dirks Associate Professor, Div. of Neurosurgery The Hospital for Sick Children 555 University Ave. Toronto, ON M5G 1X5 CANADA (416) 813-6426 (416) 813-4975 peter.dirks@sickkids.ca Dr. Adrienne Boire Memorial Sloan Kettering Cancer Ctr. 1275 York Avenue New York, NY 10065

14 

 

646-888-2063 646-422-0197 boirea@mskcc.org

Expanding the Definition of the Tumor Microenvironment Dr. David G. DeNardo Asst. Professor of Medicine Washington Univ. School of Medicine, McDonnell Genome Institute 660 S. Euclid Ave. Campus Box 8069 Saint Louis, MO 63110 (314) 362-9524 (314) 747-2797 ddenardo@wustl.edu Dr. Derek C. Radisky Professor, Cancer Biology Mayo Clinic Florida Griffin Cancer Research Building 4500 San Pablo Ave. Jacksonville, FL 32224 (904) 953-6913 (904) 953-0277 radisky.derek@mayo.edu

Molecular Mechanisms Driving Metastasis Dr. Conor C. Lynch Assistant Member, Tumor Biology Moffitt Cancer Center SRB-3 12902 Magnolia Dr. Tampa, FL 33612 (813) 745-8094 (615) 936-2911 conor.lynch@moffitt.org

15 

 

Dr. Binzhi Qian Research Associate University of Edinburgh 47 Little France Crescent Edinburgh EH164TJ SCOTLAND (646) 623-8262 qianbinzhi@gmail.com

Preclinical Studies of Cancer Prevention Dr. Zigang Dong Professor Univ. of Minnesota Hormel Inst. 801 16th Ave. N.E. Austin, MN 55912 (507) 437-9600 (507) 437-9606 zgdong@hi.umn.edu Dr. Shivendra V. Singh Professor, Dept. of Pharmacology Univ. of Pittsburgh Cancer Inst. Hillman Cancer Ctr., Room 2.32A 5117 Center Ave. Pittsburgh, PA 15213 (412) 623-3263 (412) 623-7828 singhs@upmc.edu

Endogenous and Exogenous Factors in Cancer Risk and Mortality Dr. Corinne E. Joshu Asst. Professor, Dept. of Epidemiology Johns Hopkins Univ. School of Public Health 615 N. Wolfe St. Room E6148 Baltimore, MD 21205 (443) 287-3821 cjoshu1@jhu.edu

16 

 

Dr. Siobhan Sutcliffe Sutcliffe Associate Professor, Div. of Public Health Sciences Washington Univ. School of Medicine, McDonnell Genome Institute 600 S. Taylor Ave. 2nd floor, Rm. 208S, Box 8100 Saint Louis, MO 63110 (314) 362-3788 (314) 747-3936 sutcliffes@wudosis.wustl.edu

Understanding the Genomic Dark Matter Dr. Aurora Esquela Kerscher Assistant Professor Eastern Virginia Medical School 651 Colley Ave. Lester Hall Rm. 421 Leroy T. Canoles Jr. CRC Norfolk, VA 23507 (757) 446-7191 kerschae@evms.edu Dr. Carlo M. Croce Director, Human Cancer Genetics Ohio State Univ. Comp. Cancer Ctr. 1082 Biomedical Research Tower 460 W. 12th Ave. Columbus, OH 43210 (614) 292-3063 (614) 292-3558 carlo.croce@osumc.edu

Defining New Immunotherapeutic Targets through Deep Molecular Characterization Dr. Matthew Spitzer Graduate Student, Immunology UCSF School of Medicine 513 Parnassus Ave Box 0414 San Francisco, CA 94143-0410 matthew.spitzer@ucsf.edu

17 

 

Dr. Katerina A. Politi Associate Professor, Dept. of Pathology Yale Cancer Ctr. Yale Univ. School of Medicine 310 Cedar St, SHM I-234D New Haven, CT 06520 (203) 737-5921 (203) 785-7531 katerina.politi@yale.edu

Emerging Immunotherapy Targets and Combination Strategies to Overcome Treatment Resistance Dr. Aude G. Chapuis Assistant Member Fred Hutchinson Cancer Research Ctr. D3-100 1100 Fairview Ave. N. Seattle, WA 98109 (206) 667-4369 (206) 667-7983 achapuis@fredhutch.org Dr. Patrick A. Ott Dana-Farber Cancer Institute 450 Brookline Ave Boston, MA 02215 617632-5990 Patrick_Ott@dfci.harvard.edu

Early Novel Drug Development Dr. Ricky W. Johnstone Associate Director, Laboratory Research, Co-Head, Cancer Therapeutics Program Peter MacCallum Cancer Ctr. Research Div, Level 12 Locked Bag 1, A'Beckett Street Melbourne, VIC 8006 AUSTRALIA +61 (03) 8559 7133 ricky.johnstone@petermac.org Dr. Scott A. Armstrong

18 

 

Chair, Department of Pediatric Oncology Dana-Farber Cancer Institute 450 Brookline Avenue, Dana 1642 Boston, MA 02215 (617) 632-3644 scott_armstrong@dfci.harvard.edu